Concepedia

Deirdre Allegranza

DA

Statistics

Publications

7

Citations

2.1K

H-Index

7

Active since

2014

Affiliations

Roche (Switzerland)(Current)

University of Oxford

Leipzig University

Medical University of Vienna

Roche Pharma AG (Germany)

Deirdre Allegranza is an author at Roche (Switzerland) specializing in maternal health, obstetrics, and pregnancy.

ORCID

Publications per year

2014–2018

7

Publications

7

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

Harald Zeisler, Elisa Llurba, Frédéric Chantraine et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text

, , +15

Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting

Harald Zeisler, Elisa Llurba, Frédéric Chantraine et al. · Ultrasound in Obstetrics and Gynecology · 2018 · 142 citations · Full text

, , +15

Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia

Harald Zeisler, Elisa Llurba, Frédéric Chantraine et al. · Obstetrics and Gynecology · 2016 · 87 citations

, , +17

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK

Manu Vatish, Torsten Strunz, Martin Hund et al. · Ultrasound in Obstetrics and Gynecology · 2016 · 76 citations · Full text

, , +14

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

Martin Hund, Deirdre Allegranza, Maria Schoedl et al. · BMC Pregnancy and Childbirth · 2014 · 75 citations · Full text

, , +17

1–5 of 7